1. Home
  2. LPTH vs NBTX Comparison

LPTH vs NBTX Comparison

Compare LPTH & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LightPath Technologies Inc.

LPTH

LightPath Technologies Inc.

HOLD

Current Price

$12.87

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$34.00

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LPTH
NBTX
Founded
1985
2003
Country
United States
France
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.8B
IPO Year
2011
2018

Fundamental Metrics

Financial Performance
Metric
LPTH
NBTX
Price
$12.87
$34.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$13.33
$36.00
AVG Volume (30 Days)
3.8M
54.7K
Earning Date
05-14-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,202,630.00
N/A
Revenue This Year
$83.04
$58.17
Revenue Next Year
$24.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
17.26
N/A
52 Week Low
$2.75
$4.57
52 Week High
$18.94
$57.14

Technical Indicators

Market Signals
Indicator
LPTH
NBTX
Relative Strength Index (RSI) 41.96 41.03
Support Level $12.45 $30.15
Resistance Level $13.28 $34.66
Average True Range (ATR) 1.60 2.70
MACD -0.33 -0.13
Stochastic Oscillator 2.68 32.07

Price Performance

Historical Comparison
LPTH
NBTX

About LPTH LightPath Technologies Inc.

LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: